4//SEC Filing
Elsbree David B 4
Accession 0000899243-21-000324
CIK 0001492674other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:08 PM ET
Size
10.3 KB
Accession
0000899243-21-000324
Insider Transaction Report
Form 4
Elsbree David B
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-01+34,188→ 125,269 total - Exercise/Conversion
Restricted Stock Units
2021-01-01+34,188→ 34,188 total→ Common Stock (34,188 underlying) - Award
Restricted Stock Units
2021-01-01+32,258→ 32,258 total→ Common Stock (32,258 underlying)
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2022.
- [F4]On January 1, 2020 the reporting person was granted 34,188 restricted stock units that vested on January 1, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001292650
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 3:08 PM ET
- Size
- 10.3 KB